ArticleTranslational lung cancer research2026
Remarkable response to personalized combination immunotherapy of nivolumab plus ipilimumab in an 84-year-old patient with locally advanced squamous cell carcinoma: a case report.
Ruifeng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.